Literature DB >> 2707635

Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon.

T S Halstensen1, T E Mollnes, O Fausa, P Brandtzaeg.   

Abstract

Extensively washed, ethanol fixed and paraffin embedded colonic specimens from 15 patients with ulcerative colitis (UC) and nine patients with Crohn's disease (CD) of the colon, ileal specimens from six patients with CD of the ileum, and histologically normal control specimens obtained from 10 patients operated for colonic carcinoma, were examined by immunohistochemistry with a monoclonal antibody specific for a neoepitope in the C9 part of the terminal complement complex (TCC). The submucosal blood vessels in inflammatory bowel disease (IBD) showed significantly more TCC positivity than the controls, and vascular TCC deposition was statistically related (p less than 0.001) to degree of inflammation. Five of the six ileal CD specimens contained likewise vascular TCC deposits. In addition, five UC specimens and one colonic CD specimen contained TCC-positive fibrils in the muscularis mucosae or submucosa. There was no significant difference in vascular TCC deposits between UC and CD. The results suggested that terminal complement activation takes place in the intestinal lesions of IBD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707635      PMCID: PMC1378459          DOI: 10.1136/gut.30.3.361

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

2.  Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique.

Authors:  P Brandtzaeg
Journal:  Immunology       Date:  1974-06       Impact factor: 7.397

Review 3.  The local immune response in ulcerative colitis.

Authors:  H F Otto; J O Gebbers
Journal:  Pathol Res Pract       Date:  1979-12       Impact factor: 3.250

4.  Letter: Immunohistochemical localization of complement in intestinal mucosa.

Authors:  K Baklien; P Brandtzaeg
Journal:  Lancet       Date:  1974-11-02       Impact factor: 79.321

5.  Evidence of cytotoxicity in ulcerative colitis from immunofluorescent staining of the rectal mucosa.

Authors:  J Ballard; M Shiner
Journal:  Lancet       Date:  1974-05-25       Impact factor: 79.321

6.  Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis.

Authors:  E Monteiro; J Fossey; M Shiner; B S Drasar; A C Allison
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

7.  Fc and C3b receptors on pulmonary endothelial cells: induction by injury.

Authors:  U S Ryan; D R Schultz; J W Ruan
Journal:  Science       Date:  1981-10-30       Impact factor: 47.728

8.  Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine.

Authors:  M Ligumsky; F Karmeli; P Sharon; U Zor; F Cohen; D Rachmilewitz
Journal:  Gastroenterology       Date:  1981-09       Impact factor: 22.682

9.  Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells.

Authors:  D B Cines; A P Lyss; M Bina; R Corkey; N A Kefalides; H M Friedman
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

10.  Immune-complex mediated colitis in rabbits. An experimental model.

Authors:  H J Hodgson; B J Potter; J Skinner; D P Jewell
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

View more
  19 in total

1.  Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease.

Authors:  J Laufer; R Oren; I Goldberg; A Horwitz; J Kopolovic; Y Chowers; J H Passwell
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

2.  Temporal patterns of colonic blood flow and tissue damage in an animal model of colitis.

Authors:  C B Appleyard; J L Williams; C A Hathaway; W H Percy
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

3.  Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.

Authors:  T S Halstensen; T E Mollnes; P Garred; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

4.  Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease.

Authors:  L S Toy; X Y Yio; A Lin; S Honig; L Mayer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

5.  Circulating von Willebrand factor in inflammatory bowel disease.

Authors:  T R Stevens; J P James; N J Simmonds; D A McCarthy; I F Laurenson; P J Maddison; D S Rampton
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

6.  Regulation of the alternative pathway of complement modulates injury and immunity in a chronic model of dextran sulphate sodium-induced colitis.

Authors:  M Elvington; J Schepp-Berglind; S Tomlinson
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

7.  The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.

Authors:  T Sugihara; A Kobori; H Imaeda; T Tsujikawa; K Amagase; K Takeuchi; Y Fujiyama; A Andoh
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

Review 8.  Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.

Authors:  Sonia I Vlaicu; Cosmin A Tegla; Cornelia D Cudrici; Jacob Danoff; Hassan Madani; Adam Sugarman; Florin Niculescu; Petru A Mircea; Violeta Rus; Horea Rus
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

9.  Local complement activation in inflammatory bowel disease.

Authors:  T S Halstensen; P Brandtzaeg
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

10.  Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes.

Authors:  P Hoang; B Crotty; H R Dalton; D P Jewell
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.